TARIS Biomedical a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. The TARIS core technology and development efforts are being applied to disease areas with high unmet medical need in which current therapies or systemic treatments have failed.
Current Team (11)Update
Executive Director, Program Management and Clinical Operations
Founder and Consultant
President and Chief Executive Officer
Chief Scientific Officer
Senior Vice President and Chief Business Officer
Senior Vice President, Product Development and Regulatory Affairs
Funding Rounds (4) - $51.8MUpdate
Board Members and Advisors (6)Update
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates...
Third Rock Ventures invests in transformational life science companies that show high growth...
Polaris Partners is a venture company investing in digital media, life sciences, and enterprise...
Early stage venture capital firm
99 Hayden Avenue, Suite 100
Lexington, MA 02421